These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32549314)

  • 81. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.
    Johnston RD; Stephenson MC; Crossland H; Cordon SM; Palcidi E; Cox EF; Taylor MA; Aithal GP; Macdonald IA
    Gastroenterology; 2013 Nov; 145(5):1016-1025.e2. PubMed ID: 23872500
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats.
    Wang Y; Jacome-Sosa MM; Ruth MR; Goruk SD; Reaney MJ; Glimm DR; Wright DC; Vine DF; Field CJ; Proctor SD
    J Nutr; 2009 Nov; 139(11):2049-54. PubMed ID: 19759243
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia.
    Evans K; Burdge GC; Wootton SA; Collins JM; Clark ML; Tan GD; Karpe F; Frayn KN
    Atherosclerosis; 2008 Mar; 197(1):164-70. PubMed ID: 17466309
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice.
    Salerno AG; Patrício PR; Berti JA; Oliveira HC
    Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats.
    Park J; Lemieux S; Lewis GF; Kuksis A; Steiner G
    J Lipid Res; 1997 Dec; 38(12):2529-36. PubMed ID: 9458276
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
    Qin B; Dawson H; Anderson RA
    Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.
    Stiede K; Miao W; Blanchette HS; Beysen C; Harriman G; Harwood HJ; Kelley H; Kapeller R; Schmalbach T; Westlin WF
    Hepatology; 2017 Aug; 66(2):324-334. PubMed ID: 28470676
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans.
    Vedala A; Wang W; Neese RA; Christiansen MP; Hellerstein MK
    J Lipid Res; 2006 Nov; 47(11):2562-74. PubMed ID: 16929033
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Intestinal very-low-density lipoprotein secretion in the genetically obese Zucker rat.
    Oussadou L; Kalopissis AD; Francone OL; Griffaton G
    Biochim Biophys Acta; 1988 Mar; 959(1):76-83. PubMed ID: 3345312
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Origin of hepatic very-low-density lipoprotein triacylglycerol: the contribution of cellular phospholipid.
    Wiggins D; Gibbons GF
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):673-9. PubMed ID: 8973583
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed mice.
    Nunes PM; Wright AJ; Veltien A; van Asten JJ; Tack CJ; Jones JG; Heerschap A
    FASEB J; 2014 May; 28(5):1988-97. PubMed ID: 24500922
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Delayed postprandial TAG peak after intake of SFA compared with PUFA in subjects with and without familial hypercholesterolaemia: a randomised controlled trial.
    Øyri LKL; Hansson P; Bogsrud MP; Narverud I; Florholmen G; Leder L; Byfuglien MG; Veierød MB; Ulven SM; Holven KB
    Br J Nutr; 2018 May; 119(10):1142-1150. PubMed ID: 29759104
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose.
    Tian H; Fang Y; Liu W; Wang J; Zhao J; Tang H; Yin Y; Hu Y; Peng J
    J Ethnopharmacol; 2023 Jan; 301():115806. PubMed ID: 36216198
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Metabolic fate of fructose ingested with and without glucose in a mixed meal.
    Theytaz F; de Giorgi S; Hodson L; Stefanoni N; Rey V; Schneiter P; Giusti V; Tappy L
    Nutrients; 2014 Jul; 6(7):2632-49. PubMed ID: 25029210
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women.
    Swarbrick MM; Stanhope KL; Elliott SS; Graham JL; Krauss RM; Christiansen MP; Griffen SC; Keim NL; Havel PJ
    Br J Nutr; 2008 Nov; 100(5):947-52. PubMed ID: 18384705
    [TBL] [Abstract][Full Text] [Related]  

  • 98. De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals.
    Lambert JE; Ryan EA; Thomson AB; Clandinin MT
    PLoS One; 2013; 8(12):e82530. PubMed ID: 24376543
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dietary carbohydrates and fatty liver disease: de novo lipogenesis.
    Chiu S; Mulligan K; Schwarz JM
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):277-282. PubMed ID: 29697539
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men.
    Jackson KG; Knapper-Francis JM; Morgan LM; Webb DH; Zampelas A; Williams CM
    Clin Sci (Lond); 2003 Oct; 105(4):457-66. PubMed ID: 12812518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.